(Prototype team page) |
|||
(8 intermediate revisions by 2 users not shown) | |||
Line 2: | Line 2: | ||
<html> | <html> | ||
+ | <style> | ||
+ | li{ | ||
+ | background-color: transparent; | ||
+ | } | ||
+ | </style> | ||
+ | <style> | ||
+ | *, *:before, *:after { | ||
+ | box-sizing: border-box; | ||
+ | } | ||
+ | html { | ||
+ | font-size: 18px; | ||
+ | line-height: 1.5; | ||
+ | font-weight: 300; | ||
+ | color: #333; | ||
+ | font-family: "Nunito Sans", sans-serif; | ||
+ | } | ||
− | + | body { | |
− | + | margin: 0; | |
− | + | padding: 0; | |
− | + | height: 100vh; | |
− | + | background-color: #ecf0f9; | |
+ | background-attachment: fixed; | ||
+ | } | ||
+ | .content { | ||
+ | display: flex; | ||
+ | margin: 0 auto; | ||
+ | justify-content: center; | ||
+ | align-items: center; | ||
+ | flex-wrap: wrap; | ||
+ | width: 100%; | ||
+ | padding-top: 40px; | ||
+ | padding-bottom: 40px; | ||
+ | } | ||
− | + | .heading { | |
+ | width: 100%; | ||
+ | margin-left: 1rem; | ||
+ | font-weight: 900; | ||
+ | font-size: 1.618rem; | ||
+ | text-transform: uppercase; | ||
+ | letter-spacing: .1ch; | ||
+ | line-height: 1; | ||
+ | padding-bottom: .5em; | ||
+ | margin-bottom: 1rem; | ||
+ | position: relative; | ||
+ | } | ||
+ | .heading:after { | ||
+ | display: block; | ||
+ | content: ''; | ||
+ | position: absolute; | ||
+ | width: 60px; | ||
+ | height: 4px; | ||
+ | background: linear-gradient(135deg, #1a9be6, #1a57e6); | ||
+ | bottom: 0; | ||
+ | } | ||
+ | .description { | ||
+ | width: 100%; | ||
+ | margin-top: 0; | ||
+ | margin-left: 1rem; | ||
+ | margin-bottom: 3rem; | ||
+ | } | ||
+ | .card { | ||
+ | color: inherit; | ||
+ | cursor: pointer; | ||
+ | width: 300px; | ||
+ | min-width: 300px; | ||
+ | height: 400px; | ||
+ | min-height: 400px; | ||
+ | perspective: 1000px; | ||
+ | margin: 2.5rem; | ||
+ | position: relative; | ||
+ | } | ||
+ | @media screen and (max-width: 800px) { | ||
+ | .card { | ||
+ | width: calc(50% - 2rem); | ||
+ | } | ||
+ | } | ||
+ | @media screen and (max-width: 500px) { | ||
+ | .card { | ||
+ | width: 100%; | ||
+ | } | ||
+ | } | ||
− | + | .front, | |
− | + | .back { | |
− | + | display: flex; | |
+ | border-radius: 6px; | ||
+ | background-position: center; | ||
+ | background-size: cover; | ||
+ | text-align: center; | ||
+ | justify-content: center; | ||
+ | align-items: center; | ||
+ | position: absolute; | ||
+ | height: 100%; | ||
+ | width: 100%; | ||
+ | -webkit-backface-visibility: hidden; | ||
+ | backface-visibility: hidden; | ||
+ | transform-style: preserve-3d; | ||
+ | transition: ease-in-out 600ms; | ||
+ | } | ||
− | + | .front { | |
− | + | background-size: cover; | |
− | + | padding: 2rem; | |
+ | font-size: 1.618rem; | ||
+ | font-weight: 600; | ||
+ | color: #fff; | ||
+ | overflow: hidden; | ||
+ | font-family: Poppins, sans-serif; | ||
+ | } | ||
+ | .front:before { | ||
+ | position: absolute; | ||
+ | display: block; | ||
+ | content: ''; | ||
+ | top: 0; | ||
+ | left: 0; | ||
+ | right: 0; | ||
+ | bottom: 0; | ||
+ | background: linear-gradient(135deg, #1a9be6, #1a57e6); | ||
+ | opacity: .25; | ||
+ | z-index: -1; | ||
+ | } | ||
+ | .card:hover .front { | ||
+ | transform: rotateY(180deg); | ||
+ | } | ||
+ | .card:nth-child(even):hover .front { | ||
+ | transform: rotateY(-180deg); | ||
+ | } | ||
− | + | .back { | |
− | + | background: #fff; | |
− | + | transform: rotateY(-180deg); | |
+ | padding: 0 2em; | ||
+ | } | ||
+ | .card:hover .back { | ||
+ | transform: rotateY(0deg); | ||
+ | } | ||
+ | .card:nth-child(even) .back { | ||
+ | transform: rotateY(180deg); | ||
+ | } | ||
+ | .card:nth-child(even):hover .back { | ||
+ | transform: rotateY(0deg); | ||
+ | } | ||
+ | .button { | ||
+ | transform: translateZ(40px); | ||
+ | cursor: pointer; | ||
+ | -webkit-backface-visibility: hidden; | ||
+ | backface-visibility: hidden; | ||
+ | font-weight: bold; | ||
+ | color: #fff; | ||
+ | padding: .5em 1em; | ||
+ | border-radius: 100px; | ||
+ | font: inherit; | ||
+ | background: linear-gradient(135deg, #1a9be6, #1a57e6); | ||
+ | border: none; | ||
+ | position: relative; | ||
+ | transform-style: preserve-3d; | ||
+ | transition: 300ms ease; | ||
+ | } | ||
+ | .button:before { | ||
+ | transition: 300ms ease; | ||
+ | position: absolute; | ||
+ | display: block; | ||
+ | content: ''; | ||
+ | transform: translateZ(-40px); | ||
+ | -webkit-backface-visibility: hidden; | ||
+ | backface-visibility: hidden; | ||
+ | height: calc(100% - 20px); | ||
+ | width: calc(100% - 20px); | ||
+ | border-radius: 100px; | ||
+ | left: 10px; | ||
+ | top: 16px; | ||
+ | box-shadow: 0 0 10px 10px rgba(26, 87, 230, 0.25); | ||
+ | background-color: rgba(26, 87, 230, 0.25); | ||
+ | } | ||
+ | .button:hover { | ||
+ | transform: translateZ(55px); | ||
+ | } | ||
+ | .button:hover:before { | ||
+ | transform: translateZ(-55px); | ||
+ | } | ||
+ | .button:active { | ||
+ | transform: translateZ(20px); | ||
+ | } | ||
+ | .button:active:before { | ||
+ | transform: translateZ(-20px); | ||
+ | top: 12px; | ||
+ | } | ||
+ | .nav__link:hover{ | ||
+ | background-color: transparent; | ||
+ | } | ||
+ | </style> | ||
+ | |||
+ | <style> | ||
+ | a{ | ||
+ | text-decoration: none; | ||
+ | } | ||
+ | a:hover{ | ||
+ | text-decoration: none; | ||
+ | } | ||
+ | </style> | ||
+ | </head> | ||
+ | <body style="background-color: rgb(84,146,197);"> | ||
− | |||
+ | <div class="container-fluid" style="background-color: rgb(84,146,197); padding: 40px 30px; margin-top: 35px"> | ||
+ | <div style="margin-top: 20px; width: 100px; float: left"></div> | ||
+ | <img src="https://static.igem.org/mediawiki/2018/1/1a/T--XJTLU-CHINA--lo.png" style="width: 140px; margin-top: 20px; float: left"> | ||
+ | <h1 style="font-family:'Impact'; color: white; font-size: 80px; margin-top: 20px; margin-bottom: 50px; float: left; margin-left: 20px"> | ||
+ | Demonstration | ||
+ | </h1> | ||
+ | <div class="container-fluid" style="background-color: white; box-shadow: 0px 0px 4px rgba(0,0,0,0.56); border-radius: 5px; margin-top: 200px; padding-bottom: 50px"> | ||
+ | |||
+ | <div style="text-align: center; margin-top: 50px; border-bottom: 0.8px solid #337ab7; padding-bottom: 20px"> | ||
+ | <h1 style="font-family:'Impact'; color: #337ab7"> | ||
+ | Exosome production boosting | ||
+ | </h1> | ||
+ | </div> | ||
+ | |||
+ | <div class="row" style="margin-top: 20px"> | ||
+ | <div class="col-xs-1"></div> | ||
+ | <div class="col-xs-10"> | ||
+ | <h2 style="font-family:'Impact'; color: #337ab7; margin-bottom: 20px">Experiments</h2> | ||
+ | <h3 style="font-family:'Impact'; color: #337ab7; margin-bottom: 20px">1. Exosomal biomarker synthesis</h3> | ||
+ | <p style="font-size: 17px; text-align: justify; font-weight: normal; margin-top: 20px; margin-bottom: 20px"> | ||
+ | We transfected HEK293T cells with nanoluciferase coding sequence fused with exosomal biomarker membrane protein CD63 (BBa_K2619100) for the subsequent quantification of exosomes. | ||
+ | </p> | ||
+ | </div> | ||
+ | <div class="col-xs-1"></div> | ||
+ | </div> | ||
+ | |||
+ | <div class="row" style="margin-top: 10px"> | ||
+ | <div class="col-xs-2"></div> | ||
+ | <div class="col-xs-8" style="text-align: center"> | ||
+ | <img src="https://static.igem.org/mediawiki/2018/0/09/T--XJTLU-CHINA--demo1.png" alt="..." class="img-thumbnail" style="width: 80%"> | ||
+ | <p style="text-align: center"><strong>Figure 1: Negative control was done by transfecting the HEK293T cells with empty pcDNA3.1 plasmid</strong></p> | ||
+ | </div> | ||
+ | <div class="col-xs-2"></div> | ||
+ | </div> | ||
+ | |||
+ | <div class="row" style="margin-top: 20px"> | ||
+ | <div class="col-xs-1"></div> | ||
+ | <div class="col-xs-10"> | ||
+ | <h3 style="font-family:'Impact'; color: #337ab7; margin-bottom: 20px">2. Exosome boosting analysis by luciferase assay</h3> | ||
+ | <p style="font-size: 17px; text-align: justify; font-weight: normal; margin-top: 20px; margin-bottom: 20px"> | ||
+ | Since the biomarker of exosomes was synthesized successfully in experiment 1. | ||
+ | We then conducted experiments to test the exosome production boosting ability of our deigned devices (BBa_K2619014—nSMase and BBa_K2619103—Booster) by co-transfection. | ||
+ | </p> | ||
+ | </div> | ||
+ | <div class="col-xs-1"></div> | ||
+ | </div> | ||
+ | |||
+ | <div class="row" style="margin-top: 10px"> | ||
+ | <div class="col-xs-2"></div> | ||
+ | <div class="col-xs-8" style="text-align: center"> | ||
+ | <img src="https://static.igem.org/mediawiki/2018/c/cb/T--XJTLU-CHINA--demo2.png" alt="..." class="img-thumbnail" style="width: 80%"> | ||
+ | <p style="text-align: center"> | ||
+ | <strong> | ||
+ | Figure 2: NC: negative control; | ||
+ | done by transfecting CD63-nluc and empty pcDNA3.1 plasmid (1:2 ratio). | ||
+ | Booster: Steap-SDC4-NadB (BBa_2619103); done by transfecting CD63-nluc, | ||
+ | Booster and pcDNA3.1 plasmid (1:1:1 ratio). Booster nSMase: done by transfecting Booster, | ||
+ | nSMase and CD63-nluc (1:1:1 ratio) | ||
+ | </strong> | ||
+ | </p> | ||
+ | </div> | ||
+ | <div class="col-xs-2"></div> | ||
+ | </div> | ||
+ | |||
+ | <div class="row" style="margin-top: 20px"> | ||
+ | <div class="col-xs-1"></div> | ||
+ | <div class="col-xs-10"> | ||
+ | <h3 style="font-family:'Impact'; color: #337ab7; margin-bottom: 20px"> | ||
+ | 3. Exosome production boosting analysis by Pierce BCA protein assay | ||
+ | </h3> | ||
+ | <p style="font-size: 17px; text-align: justify; font-weight: normal; margin-top: 20px; margin-bottom: 20px"> | ||
+ | Our team utilized varied methods to confirm the validity of exosomal production enhancement of Booster and nSMase. | ||
+ | </p> | ||
+ | </div> | ||
+ | <div class="col-xs-1"></div> | ||
+ | </div> | ||
+ | |||
+ | <div class="row" style="margin-top: 10px"> | ||
+ | <div class="col-xs-2"></div> | ||
+ | <div class="col-xs-8" style="text-align: center"> | ||
+ | <img src="https://static.igem.org/mediawiki/2018/4/41/T--XJTLU-CHINA--demo3.png" alt="..." class="img-thumbnail" style="width: 80%"> | ||
+ | <p style="text-align: center"> | ||
+ | <strong> | ||
+ | Figure 3: NC: negative control; done by transfecting empty pcDNA3.1 plasmid. | ||
+ | Booster: Steap-SDC4-NadB; done by transfecting Booster and pcDNA3.1 plasmid (1:1 ratio). | ||
+ | Booster nSMase: done by transfecting Booster and nSMase (1:1 ratio) | ||
+ | </strong> | ||
+ | </p> | ||
+ | </div> | ||
+ | <div class="col-xs-2"></div> | ||
+ | </div> | ||
+ | |||
+ | <div class="row" style="margin-top: 20px"> | ||
+ | <div class="col-xs-1"></div> | ||
+ | <div class="col-xs-10"> | ||
+ | <h3 style="font-family:'Impact'; color: #337ab7; margin-bottom: 20px"> | ||
+ | 4. Exosome production boosting analysis by nanoparticle tracking assay (NTA) | ||
+ | </h3> | ||
+ | <p style="font-size: 17px; text-align: justify; font-weight: normal; margin-top: 20px; margin-bottom: 20px"> | ||
+ | The third method of verifying the devices capacity in exosome production enhancement is doing NTA by NanosightTM. | ||
+ | After purification of exosomes by Total Exosome Isolation Reagent (Thermo ScientificTM), | ||
+ | the exact secreted particle numbers were analyzed. | ||
+ | </p> | ||
+ | </div> | ||
+ | <div class="col-xs-1"></div> | ||
+ | </div> | ||
+ | |||
+ | <div class="row" style="margin-top: 10px"> | ||
+ | <div class="col-xs-2"></div> | ||
+ | <div class="col-xs-8" style="text-align: center"> | ||
+ | <img src="https://static.igem.org/mediawiki/2018/6/64/T--XJTLU-CHINA--demo4.png" alt="..." class="img-thumbnail" style="width: 80%"> | ||
+ | <p style="text-align: center"> | ||
+ | <strong> | ||
+ | Figure 4: NC: negative control; done by transfecting empty pcDNA3.1 plasmid. | ||
+ | Booster: Steap-SDC4-NadB; done by transfecting Booster and pcDNA3.1 plasmid (1:1 ratio). | ||
+ | Booster nSMase: done by transfecting Booster and nSMase (1:1 ratio) | ||
+ | </strong> | ||
+ | </p> | ||
+ | </div> | ||
+ | <div class="col-xs-2"></div> | ||
+ | </div> | ||
+ | |||
+ | <div class="row" style="margin-top: 20px"> | ||
+ | <div class="col-xs-1"></div> | ||
+ | <div class="col-xs-10"> | ||
+ | <h2 style="font-family:'Impact'; color: #337ab7; margin-bottom: 20px"> | ||
+ | Conclusion | ||
+ | </h2> | ||
+ | <p style="font-size: 17px; text-align: justify; font-weight: normal; margin-top: 20px; margin-bottom: 20px"> | ||
+ | A combination of two exosome production accelerators/enhancing devices is reported to be the most capable of boosting the cells in exosome production. | ||
+ | </p> | ||
+ | </div> | ||
+ | <div class="col-xs-1"></div> | ||
+ | </div> | ||
+ | |||
+ | <div style="text-align: center; margin-top: 50px; border-bottom: 0.8px solid #337ab7; padding-bottom: 20px"> | ||
+ | <h1 style="font-family:'Impact'; color: #337ab7"> | ||
+ | Neuronal cell targeting experiments | ||
+ | </h1> | ||
+ | </div> | ||
+ | |||
+ | <div class="row" style="margin-top: 20px"> | ||
+ | <div class="col-xs-1"></div> | ||
+ | <div class="col-xs-10"> | ||
+ | <h2 style="font-family:'Impact'; color: #337ab7; margin-bottom: 20px"> | ||
+ | Lamp2b protein linkage experiment | ||
+ | </h2> | ||
+ | <p style="font-size: 17px; text-align: justify; font-weight: normal; margin-top: 20px; margin-bottom: 20px"> | ||
+ | We fused nanoluciferase gene with exosomal membrane protein Lamp2b to examine its downstream gene expression. (Lamp2b-nluc, BBa_K2619113). | ||
+ | </p> | ||
+ | </div> | ||
+ | <div class="col-xs-1"></div> | ||
+ | </div> | ||
+ | |||
+ | <div class="row" style="margin-top: 10px; margin-bottom: 40px"> | ||
+ | <div class="col-xs-2"></div> | ||
+ | <div class="col-xs-8" style="text-align: center"> | ||
+ | <img src="https://static.igem.org/mediawiki/2018/4/47/T--XJTLU-CHINA--demo5.png" alt="..." class="img-thumbnail" style="width: 80%"> | ||
+ | <p style="text-align: center"> | ||
+ | <strong> | ||
+ | Figure 5: NC: negative control; done by transfecting empty pcDNA3.1 plasmid. | ||
+ | </strong> | ||
+ | </p> | ||
+ | </div> | ||
+ | <div class="col-xs-2"></div> | ||
+ | </div> | ||
+ | |||
+ | |||
+ | |||
+ | |||
+ | </div> | ||
+ | |||
+ | |||
+ | <div style="background-color: white; box-shadow: 0px 0px 4px rgba(0,0,0,0.56); border-radius: 5px; margin-top: 50px; background-color: white; padding-bottom: 40px"> | ||
+ | <div> | ||
+ | |||
+ | </div> | ||
+ | <div style="text-align: center; padding-top: 40px"> | ||
+ | <h1 style="margin: 0px auto; font-family:'Impact'; color: #337ab7">Collaborators and Supporters</h1> | ||
+ | </div> | ||
+ | <div class="container-fluid" style="margin-top: 50px"> | ||
+ | <div class="row" style="padding: 0px 100px"> | ||
+ | <div class="col-md-4" style="padding-left:5%; padding-right:5%;"> | ||
+ | <div style="height: 100%"> | ||
+ | <img style="margin-top: 80px; width: 100%" src="https://static.igem.org/mediawiki/2018/3/3a/T--XJTLU-CHINA--qide.png"> | ||
+ | <img style="margin-top: 120px; width: 100%" src="https://static.igem.org/mediawiki/2018/3/3d/T--XJTLU-CHINA--NEB_logo.png"> | ||
+ | </div> | ||
+ | </div> | ||
+ | <div class="col-md-4" style="padding:0 5%;"> | ||
+ | <div style="height: 100%"> | ||
+ | <img src="https://static.igem.org/mediawiki/2018/b/b9/T--XJTLU-CHINA--genscript.png" style="width: 100%"> | ||
+ | <img style="margin-top: 30px; width: 100%" src="https://static.igem.org/mediawiki/2018/0/02/T--XJTLU-CHINA--xjtlubio.png"> | ||
+ | <img style="margin-top: 20px; width: 100%" src="https://static.igem.org/mediawiki/2018/1/10/T--XJTLU-CHINA--fundgai.png"> | ||
+ | </div> | ||
+ | </div> | ||
+ | <div class="col-md-4" style="padding:0 5%;"> | ||
+ | <div> | ||
+ | <img style="margin-top: 90px; width: 100%" src="https://static.igem.org/mediawiki/2018/3/36/T--XJTLU-CHINA--math.png"> | ||
+ | <img style="margin-top: 150px; width: 100%" src="https://static.igem.org/mediawiki/2018/0/0a/T--XJTLU-CHINA--Synbio.png"> | ||
+ | </div> | ||
+ | </div> | ||
+ | </div> | ||
+ | </div> | ||
+ | </div> | ||
+ | <div class="container-fluid" style="border-top: 1px solid rgba(0,0,0,0.15); height: 240px; padding-top: 30px; background-color: rgb(84,146,197);"> | ||
+ | <div class="row" style="padding: 0px 50px"> | ||
+ | <div class="col-md-1"></div> | ||
+ | <div class="col-md-4"> | ||
+ | <div> | ||
+ | <p style="font-size: 26px; font-family:'Open-Sans-L'; color: white;">Location</p> | ||
+ | </div> | ||
+ | <div> | ||
+ | <p style="line-height: 15px; font-size: 16px;font-family:'Lato-Light'; color: white;">Rm 363, Science Building</p> | ||
+ | <p style="line-height: 15px; font-size: 16px;font-family:'Lato-Light'; color: white;">Xi'an Jiaotong-Liverpool University</p> | ||
+ | <p style="line-height: 15px; font-size: 16px;font-family:'Lato-Light'; color: white;">111 Ren'ai Road, Suzhou, China</p> | ||
+ | <p style="line-height: 16px; font-size: 16px;font-family:'Lato-Light'; color: white;">215123</p> | ||
+ | </div> | ||
+ | </div> | ||
+ | <div class="col-md-4"> | ||
+ | <div> | ||
+ | <p style="font-size: 26px; font-family:'Open-Sans-L'; color: white;">Social</p> | ||
+ | </div> | ||
+ | <div> | ||
+ | <p style="line-height: 15px; font-size: 16px;font-family:'Lato-Light'; color: white;">FB</p> | ||
+ | </div> | ||
+ | </div> | ||
+ | <div class="col-md-3"> | ||
+ | <div> | ||
+ | <p style="font-size: 26px; font-family:'Open-Sans-L'; color: white;">Get in touch</p> | ||
+ | </div> | ||
+ | <div> | ||
+ | <p style="line-height: 15px; font-size: 16px;font-family:'Lato-Light'; color: white;">igem@xjtlu.edu.cn</p> | ||
+ | </div> | ||
+ | </div> | ||
+ | </div> | ||
+ | </div> | ||
+ | |||
+ | </div> | ||
+ | </body> | ||
</html> | </html> |
Latest revision as of 01:06, 18 October 2018
Demonstration
Exosome production boosting
Experiments
1. Exosomal biomarker synthesis
We transfected HEK293T cells with nanoluciferase coding sequence fused with exosomal biomarker membrane protein CD63 (BBa_K2619100) for the subsequent quantification of exosomes.
Figure 1: Negative control was done by transfecting the HEK293T cells with empty pcDNA3.1 plasmid
2. Exosome boosting analysis by luciferase assay
Since the biomarker of exosomes was synthesized successfully in experiment 1. We then conducted experiments to test the exosome production boosting ability of our deigned devices (BBa_K2619014—nSMase and BBa_K2619103—Booster) by co-transfection.
Figure 2: NC: negative control; done by transfecting CD63-nluc and empty pcDNA3.1 plasmid (1:2 ratio). Booster: Steap-SDC4-NadB (BBa_2619103); done by transfecting CD63-nluc, Booster and pcDNA3.1 plasmid (1:1:1 ratio). Booster nSMase: done by transfecting Booster, nSMase and CD63-nluc (1:1:1 ratio)
3. Exosome production boosting analysis by Pierce BCA protein assay
Our team utilized varied methods to confirm the validity of exosomal production enhancement of Booster and nSMase.
Figure 3: NC: negative control; done by transfecting empty pcDNA3.1 plasmid. Booster: Steap-SDC4-NadB; done by transfecting Booster and pcDNA3.1 plasmid (1:1 ratio). Booster nSMase: done by transfecting Booster and nSMase (1:1 ratio)
4. Exosome production boosting analysis by nanoparticle tracking assay (NTA)
The third method of verifying the devices capacity in exosome production enhancement is doing NTA by NanosightTM. After purification of exosomes by Total Exosome Isolation Reagent (Thermo ScientificTM), the exact secreted particle numbers were analyzed.
Figure 4: NC: negative control; done by transfecting empty pcDNA3.1 plasmid. Booster: Steap-SDC4-NadB; done by transfecting Booster and pcDNA3.1 plasmid (1:1 ratio). Booster nSMase: done by transfecting Booster and nSMase (1:1 ratio)
Conclusion
A combination of two exosome production accelerators/enhancing devices is reported to be the most capable of boosting the cells in exosome production.
Neuronal cell targeting experiments
Lamp2b protein linkage experiment
We fused nanoluciferase gene with exosomal membrane protein Lamp2b to examine its downstream gene expression. (Lamp2b-nluc, BBa_K2619113).
Figure 5: NC: negative control; done by transfecting empty pcDNA3.1 plasmid.
Collaborators and Supporters
Location
Rm 363, Science Building
Xi'an Jiaotong-Liverpool University
111 Ren'ai Road, Suzhou, China
215123
Social
FB
Get in touch
igem@xjtlu.edu.cn